Deregulation of protein phosphatase expression in acute myeloid leukemia

Medical Oncology

Volumn 30, Issue 2, 2013, Pages

  Kabir, Nuzhat N ^a   Rönnstrand, Lars ^b   Kazi, Julhash U ^a,b  

^a KN Biomedical Research Institute   (Bangladesh)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Acute myeloid leukemia; AML; Dual specificity protein phosphatase; Protein phosphatase; Protein serine threonine phosphatase; Protein tyrosine phosphatase

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE; MESSENGER RNA; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; ENZYME REGULATION; HUMAN; HUMAN GENOME; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL TRANSFORMATION; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; PHOSPHOPROTEIN PHOSPHATASES; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84874088035     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0517-8     Document Type: Article

References (22)

1. Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453-74. doi: 10.1182/blood-2009-07-235358.
2. Kabir NN, Kazi JU. Comparative analysis of human and bovine protein kinases reveals unique relationship and functional diversity. Genet Mol Biol. 2011;34(4):587-91. doi: 10.1590/S1415-47572011005000035.
3. Kazi JU, Kabir NN, Soh JW. Bioinformatic prediction and analysis of eukaryotic protein kinases in the rat genome. Gene. 2008;410(1):147-53. doi: 10.1016/j.gene.2007.12.003.
4. Caenepeel S, Charydczak G, Sudarsanam S, Hunter T, Manning G. The mouse kinome: discovery and comparative genomics of all mouse protein kinases. Proc Natl Acad Sci USA. 2004;101(32):11707-12. doi: 10.1073/pnas.0306880101.
5. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298(5600):1912-34. doi: 10.1126/science.1075762.
6. Porcu M, Kleppe M, Gianfelici V, Geerdens E, De Keersmaecker K, Tartaglia M, et al. Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia. Blood. 2012;119(19):4476-9. doi: 10.1182/blood-2011-09-379958.
7. Godfrey R, Arora D, Bauer R, Stopp S, Muller JP, Heinrich T, et al. Cell transformation by FLT3 ITD in acute myeloid leukemia involves oxidative inactivation of the tumor suppressor protein-tyrosine phosphatase DEP-1/PTPRJ. Blood. 2012;119(19):4499-511. doi: 10.1182/blood-2011-02-336446.
8. Arora D, Kothe S, van den Eijnden M, Hooft van Huijsduijnen R, Heidel F, Fischer T, et al. Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression. Cell Commun Signal CCS. 2012;10(1):19. doi: 10.1186/1478-811X-10-19.
9. Kazi JU, Sun J, Phung B, Zadjali F, Flores-Morales A, Ronnstrand L. Suppressor of cytokine signaling 6 (SOCS6) negatively regulates Flt3 signal transduction through direct binding to phosphorylated tyrosines 591 and 919 of Flt3. J Biol Chem. 2012;287(43):36509-17. doi: 10.1074/jbc.M112.376111.
10. Kazi JU, Ronnstrand L. FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia. Mol Oncol. 2012;. doi: 10.1016/j.molonc.2012.11.003.
11. Kazi JU, Ronnstrand L. Src-Like Adaptor Protein (SLAP) binds to the receptor tyrosine kinase Flt3 and modulates receptor stability and downstream signaling. PLoS ONE. 2012;7(12):e53509. doi: 10.1371/journal.pone.0053509.
12. Kabir NN, Ronnstrand L, Kazi JU. Protein Kinase C (PKC) expression is deregulated in chronic lymphocytic leukemia. Leuk Lymphoma. 2013;. doi: 10.3109/10428194.2013.769220.
13. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, et al. Protein tyrosine phosphatases in the human genome. Cell. 2004;117(6):699-711.
14. Forrest AR, Ravasi T, Taylor D, Huber T, Hume DA, Grimmond S. Phosphoregulators: protein kinases and protein phosphatases of mouse. Genome Res. 2003;13(B6):1443-54.
15. Stirewalt DL, Meshinchi S, Kopecky KJ, Fan W, Pogosova-Agadjanyan EL, Engel JH, et al. Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes Chromosom Cancer. 2008;47(1):8-20. doi: 10.1002/gcc.20500.
16. Metzeler KH, Hummel M, Bloomfield CD, Spiekermann K, Braess J, Sauerland MC, et al. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood. 2008;112(10):4193-201. doi: 10.1182/blood-2008-02-134411.
17. Yagi T, Morimoto A, Eguchi M, Hibi S, Sako M, Ishii E, et al. Identification of a gene expression signature associated with pediatric AML prognosis. Blood. 2003;102(5):1849-56. doi: 10.1182/blood-2003-02-0578.
18. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med. 2004;350(16):1605-16. doi: 10.1056/NEJMoa031046.
19. Gutierrez NC, Lopez-Perez R, Hernandez JM, Isidro I, Gonzalez B, Delgado M, et al. Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia. Leuk Off J Leuk Soc Am Leuk Res Fund UK. 2005;19(3):402-9. doi: 10.1038/sj.leu.2403625.
20. Ruela-de-Sousa RR, Queiroz KC, Peppelenbosch MP, Fuhler GM. Reversible phosphorylation in haematological malignancies: potential role for protein tyrosine phosphatases in treatment? Biochim Biophys Acta. 2010;1806(2):287-303. doi: 10.1016/j.bbcan.2010.07.007.
21. Nomura M, Shiiba K, Katagiri C, Kasugai I, Masuda K, Sato I, et al. Novel function of MKP-5/DUSP10, a phosphatase of stress-activated kinases, on ERK-dependent gene expression, and upregulation of its gene expression in colon carcinomas. Oncol Rep. 2012;28(3):931-6. doi: 10.3892/or.2012.1862.
22. Hao L, ElShamy WM. BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR. Int J Cancer J Int du Cancer. 2007;121(1):39-46. doi: 10.1002/ijc.22597.